Robin Shane Readnour
Director at AN2 Therapeutics · 4 reported transactions in 1 company · latest trade Sep 9, 2026
Their trades
Sold | Sep 9, 2026 | Sep 9, 2026 close $5.73 → Oct 29, 2026 close $4.69. S&P 500 +1.3% over the same days. | ||
Sold | Sep 9, 2026 | Sep 9, 2026 close $5.73 → Oct 29, 2026 close $4.69. S&P 500 +1.3% over the same days. | ||
Sold | Aug 17, 2026 | Aug 17, 2026 close $5.73 → Oct 29, 2026 close $4.69. S&P 500 −0.1% over the same days. | ||
Sold | Aug 17, 2026 | Aug 17, 2026 close $5.73 → Oct 29, 2026 close $4.69. S&P 500 −0.1% over the same days. |
SoldAN2 Therapeutics
$3.5K
Sep 9, 2026 close $5.73 → Oct 29, 2026 close $4.69. S&P 500 +1.3% over the same days.
SoldAN2 Therapeutics
$3.2K
Sep 9, 2026 close $5.73 → Oct 29, 2026 close $4.69. S&P 500 +1.3% over the same days.
SoldAN2 Therapeutics
$112.4K
Aug 17, 2026 close $5.73 → Oct 29, 2026 close $4.69. S&P 500 −0.1% over the same days.
SoldAN2 Therapeutics
$100.3K
Aug 17, 2026 close $5.73 → Oct 29, 2026 close $4.69. S&P 500 −0.1% over the same days.